Considering the important profibrotic effects of TGF-β1 in renal tubulointerestital fibrosis, we therefore study the role of moesin in such process so as to provide novel therapeutical targets for renal fibrosis and CKD. The gene discussed is MSN; the disease is chronic kidney disease.